Tumor endothelial cell‐induced CD8+ T‐cell exhaustion via GPNMB in hepatocellular carcinoma
Open Access
- 24 March 2022
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 113 (5) , 1625-1638
Abstract
Tumor endothelial cells (TECs) promote tumor angiogenesis and regulate cytotoxic T cells in the tumor microenvironment. However, the roles of TECs for tumor‐infiltrating T‐cell in hepatocellular carcinoma (HCC) is still unknown. Here, we aimed to investigate how TECs influenced tumor growth and immune responses of HCC focusing on CD8+ T‐cell infiltration and exhaustion. First, TECs were isolated from subcutaneous HCC tumors with murine HCC cell lines (BNL‐T) with magnetic selection of CD31+ cells, and normal endothelial cells (NECs) were isolated from normal liver. Second, immunocompetent mice were injected with BNL‐T alone, BNL‐T + NECs, or BNL‐T + TECs for tumor formation, and the functions and exhaustion of tumor‐infiltrating CD8+ T cells were evaluated. The mice injected with BNL‐T + TEC showed rapid tumorigenesis and a decrease in the number of infiltrating CD8+ T cells. In addition, the percentage of CD8+ T‐cell exhaustion was significantly higher in tumors from the administration of BNL‐T + TEC. Third, the next‐generation sequencing on TECs was performed to identify mRNAs that might be a novel treatment target. The molecule of glycoprotein nonmetastatic melanoma protein B (GPNMB) was identified and the functions of GPNMB was analyzed by silencing of GPNMB expression using small interfering RNAs. The silencing of GPNMB expression in TECs induced the suppression of tumor growth and T‐cell exhaustion. In conclusion, TECs induced tumor‐infiltrating T‐cell exhaustion via GPNMB expression and GPNMB might be a novel therapeutic target in HCC.Keywords
This publication has 47 references indexed in Scilit:
- Tolerance and exhaustion: defining mechanisms of T cell dysfunctionTrends in Immunology, 2014
- Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancerOncoTargets and Therapy, 2013
- Activated tumor-infiltrating CD4+ regulatory T cells restrain antitumor immunity in patients with primary or metastatic liver cancerHepatology, 2012
- The potential of GPNMB as novel neuroprotective factor in amyotrophic lateral sclerosisScientific Reports, 2012
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunityJournal of Experimental Medicine, 2010
- DC-HIL/Glycoprotein Nmb Promotes Growth of Melanoma in Mice by Inhibiting the Activation of Tumor-Reactive T CellsCancer Research, 2010
- Isolated tumor endothelial cells maintain specific character during long-term cultureBiochemical and Biophysical Research Communications, 2010
- NY-ESO-1 Expression and Immunogenicity in Esophageal CancerClinical Cancer Research, 2004
- Molecular regulation of vessel maturationNature Medicine, 2003
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002